Post-Genomics and Vaccine Improvement for Leishmania

Post-Genomics and Vaccine Improvement for Leishmania

Leishmaniasis is a parasitic disease that primarily affects Asia, Africa, South America and the Mediterranean basin. Despite extensive efforts to develop an effective prophylactic vaccine, no promising vaccine is available yet. However, recent advancements in computational vaccinology on the one han...

Full description

Bibliographic Details
Main Authors: Negar eSeyed, Tahereh eTaheri, Sima eRafati
Format: Article
Language:English
Published: Frontiers Media S.A. 2016-04-01
Series:Frontiers in Microbiology
Subjects:
Genome
Leishmania
reverse vaccinology
T cell vaccine
conventional vaccine
Online Access:http://journal.frontiersin.org/Journal/10.3389/fmicb.2016.00467/full

Similar Items

Similar Items